BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 1, 2022
View Archived Issues
CRV-431 is a possible treatment approach for ALD
Read More
Thrombospondin-1 found to be involved in pathogenesis of acute-on-chronic liver failure
Read More
Albireo patents SLC10A1 and/or SLC10A2 inhibitors
Read More
Qurient Therapeutics discloses new CDK7 inhibitors
Read More
Tuojie Biotech identifies new P2X3 antagonists
Read More
Stingray Therapeutics synthesizes ENPP1 inhibitors
Read More
Roche discovers new EGFR mutant inhibitors for NSCLC
Read More
KLB as a novel druggable target for the prevention of NAFLD
Read More
CSF1R inhibition could delay muscular dystrophy progression
Read More
Extended funding supports Errium's development of therapeutics for chronic autoimmune diseases
Read More
Ildong licenses Twist VHH antibody libraries for antibody discovery in immuno-oncology
Read More
China NMPA approves IND for Henlius' anti-TIGIT Fc fusion protein HLX-53
Read More
Anti-alpha-1-antitrypsin BMN-349 reverses liver disease in a preclinical model
Read More
Sutro Biopharma generates hemiasterlin/TLR agonist dual-conjugate anti-FolR-alpha ADCs
Read More
ENT1 inhibitor reverses sporadic Alzheimer's disease in mice
Read More